Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Urology

• Publication date

  2000-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0090-4295(00)00648-8PMID 10962307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor I and prostate cancer.

  2001cited by this paper
• A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men.

  2000cited by this paper
• Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3

  1999cited by this paper
• Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

  1999cited by this paper
• Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

  1999cited by this paper
• Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.

  1998cited by this paper
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer.

  1998cited by this paper
• Castration-Induced Apoptosis in the Rat Ventral Prostate Is Associated with Increased Expression of Genes Encoding Insulin-Like Growth Factor Binding Proteins 2, 3, 4 and 5.

  1998cited by this paper
• Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.

  1998cited by this paper
• A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.

  1998cited by this paper
• Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5.

  1998cited by this paper
• National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening.

  1998cited by this paper
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

  1998cited by this paper
• Expression of Insulin-Like Growth Factor-2 Can Predict the Prognosis of Human Colorectal Cancer Patients: Correlation with Tumor Progression, Proliferative Activity and Survival

  1998cited by this paper
• Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

  1998cited by this paper
• Insulin‐like growth factor‐binding protein‐2 in patients with prostate carcinoma and benign prostatic hyperplasia

  1997cited by this paper
• Insulin‐like growth factor‐binding protein‐2 in patients with prostate carcinoma and benign prostatic hyperplasia

  1997cited by this paper
• Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

  1997cited by this paper
• Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.

  1997cited by this paper
• Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer.

  1997cited by this paper
• Insulin‐like growth factor‐II as a prognostic factor in pulmonary adenocarcinoma

  1996cited by this paper
• Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up.

  1996cited by this paper
• Longitudinal screening for prostate cancer with prostate-specific antigen.

  1996cited by this paper
• Prognostic significance of positive surgical margins in radical prostatectomy specimens.

  1995cited by this paper
• Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis.

  1995cited by this paper
• Nutritional regulation of the insulin-like growth factors.

  1994cited by this paper
• Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease.

  1994cited by this paper
• Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.

  1993cited by this paper
• Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.

  1993cited by this paper
• Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.

  1993cited by this paper
• Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma.

  1992cited by this paper
• Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade and local tumor extension.

  1990cited by this paper
• Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.

  1990cited by this paper
• Anatomic considerations in carcinoma of the prostate.

  1989cited by this paper
• A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

  1985cited by this paper

• Immunohistochemical study of insulin-like growth factor 1 in calcifying epithelial odontogenic tumor and ameloblastoma: experimental research

  2023cites this paper
• Targeting the splice factor kinase CLK1 in prostate cancer cells

  2020cites this paper
• Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model

  2019cites this paper
• Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis

  2017cites this paper
• Prostate cancer markers: An update.

  2016cites this paper
• Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer

  2014cites this paper
• Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.

  2011cites this paper
• Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model.

  2011cites this paper
• Implications of insulin‐like growth factor‐I for prostate cancer therapies

  2009cites this paper
• Évolution de la cellule normale à la cellule cancéreuse prostatique hormonodépendante–hormono-indépendante

  2008cites this paper
• Molecular markers in the diagnosis of prostate cancer

  2007cites this paper
• Molecular markers in the diagnosis of prostate cancer.

  2007cites this paper
• Prognostic factors in prostate cancer

  2006cites this paper
• Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?

  2006cites this paper
• IGF-I measurements. Epidemiological and clinical aspects.

  2005cites this paper
• Early effects of castration therapy in non-malignant and malignant prostate tissue

  2005cites this paper
• Serum Insulin-Like Growth Factor-I Levels and Prostatic Intraepithelial Neoplasia: A Clue to the Relationship Between IGF-I Physiology and Prostate Cancer Risk

  2005cites this paper
• IGF-I Measurements

  2005cites this paper
• IGF1 (CA)19 Repeat and IGFBP3 -202 A/C Genotypes and the Risk of Prostate Cancer in Black and White Men

  2005cites this paper
• Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.

  2004cites this paper
• Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.

  2004cites this paper
• Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: Predictive value of serum chromogranin A

  2004cites this paper
• Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma

  2004cites this paper
• [Androgens and prostate: basic research and clinical data].

  2004cites this paper
• Serum insulin‐like growth factor (IGF)‐1 and IGF‐binding protein‐3 do not correlate with Gleason score or quantity of prostate cancer in biopsy samples

  2003influential citation
• Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.

  2003cites this paper
• Biochemical staging of prostate cancer.

  2003cites this paper
• Serum Insulin-like Growth Factor I : Tumor Marker or Etiologic Factor ?

  2003cites this paper
• Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

  2003cites this paper
• Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

  2003cites this paper
• Serum Insulin-like Growth Factor I : Tumor Marker or Etiologic Factor ? A Prospective Study of Prostate Cancer among Finnish Men 1

  2003cites this paper
• C: IGF-I l IGFBP-3 l ☆

  2003cites this paper
• Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.

  2002cites this paper
• Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.

  2002cites this paper
• Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cites this paper
• Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cites this paper
• Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.

  2002cites this paper
• Insulin-like Growth Factors and Prostate Cancer

  2001cites this paper
• Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

  2001cites this paper
• Prostate Cancer: Risk Assessment and Diagnostic Approaches TH I NTERNATIONAL P ROSTATE C ANCER U PDATE

  2001cites this paper
• Prostate cancer: risk assessment and diagnostic approaches.

  2001cites this paper
• Insulin-like growth factors and prostate cancer.

  2001cites this paper
• Oncology: prostate and renal Complementary medicine for the prevention or treatment of prostate cancer Related review: Fat reduction to prevent prostate cancer: waiting for more evidence?

  2001cites this paper
• Best of the 1999 AUA Annual Meeting: Highlights from the American Urological Association Annual Meeting May 1-6, 1999, Dallas, Texas.

  1999cites this paper